Verdict: Side-by-side breakdown using the Bull Rankings model. PRVA scored 56.0, HQY scored 69.2 — HQY leads.
Compare another set
PRVA
Privia Health Group, Inc.
Health Information Services · Quality-Growth
56
$20.85 · $2.7B
fundamentals as of
Score gap
13.2
HQY leads
HQY
HealthEquity, Inc.
Health Information Services · Quality-Growth
69.2
$92.61 · $7.7B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
CheapestHQY33.4x
Fastest growthPRVA+24.1%
Strongest balance sheetPRVA0.01
Highest qualityHQY71 / 100
Largest discount to fair valuePRVA-20%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
PRVA
stronger →← stronger
HQY
44
Qualityreturns · margins · balance sheet
71
79
Growthrevenue & earnings expansion
78
50
Valuevaluation vs sector peers
60
HQY is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
PRVA
HQY
$131mC
FCF
$437mC
+24.1%A-
Rev
+9.5%B
0.01A-
D/E
0.49B
99.3xD
P/E
33.4xC+
27.41D
PEG
1.14B+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
PRVA
HQY
20% below
Price vs fair valuelower is cheaper
2% below
~7%/yr
Growth the price impliesyr-1 FCF growth, fading to 4% · lower = less priced in
~8%/yr
+1%
1-yr DCF upside
-9%
+25%
5-yr DCF upside
+2%
+74%
10-yr DCF upside
+19%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
PRVA
Why this score
Diluting shareholders
HQY
Why this score
Buying back stock
The companies
PRVAPrivia Health Group, Inc.
Health Information Services · $20.85 · beta 0.80
Why now
Health Information Services · market cap $2.7b. Down 28% from 52-week high of $28.82 — deep drawdown territory. Revenue growing +24%, comfortably above the S&P median. 17 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $31.47 (implying +51% upside).
Moat
Free cash flow runs well ahead of reported net income, mostly because of stock-based pay ($76m) — a real cost to shareholders, paid in shares rather than cash.
Risk
Trailing P/E 99.3x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Net margin 1.2% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first. ROE 4% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
HQYHealthEquity, Inc.
Health Information Services · $92.61 · beta 0.24
Why now
Health Information Services · market cap $7.7b. 14% off the 52-week high of $107.62. 15 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $119.33 (implying +29% upside).
Moat
Net margin 17% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 11% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. FCF converts 185% of net income — earnings translate cleanly into cash.
Risk
Trailing P/E 33x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where PRVA and HQY diverge
On the headline score the gap is 13.2 points in favor of HQY. The widest single difference is Quality, where HQY leads by 26.9 points.
QualityPRVA 44.2 · HQY 71.1HQY +26.9
ValuePRVA 50.4 · HQY 59.9HQY +9.5
GrowthPRVA 78.7 · HQY 77.9level
Pillars run 0–100. Value is judged against each company's own sector, so a Value score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.
Common questions
Is HQY or PRVA the better stock?
HQY scores higher: HQY 69.2, PRVA 56.0 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.
Where do HQY and PRVA differ most?
The widest gap is quality, where HQY leads by 27 points on the 0–100 pillar scale. HQY also leads value, while growth is effectively level between them.
How are HQY and PRVA scored?
Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.
How current is this comparison?
The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.